Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Adi Peg20
2. Adi-peg20
3. Pegylated Arginine Deiminase
1. Peg21
2. 351342-08-0
3. Ho-peg20-oh
4. 3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57-nonadecaoxanonapentacontane-1,59-diol
5. Peg 20
6. Mfcd09910396
7. 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol
8. Pegylated Arginine Deiminase
9. Pegargiminasum
10. Pegargiminasa
11. 9fo
12. Eicosa-ethylene Glycol
13. Adi-peg
14. Adi-ss
15. Adipeg20
16. 0b7pyq9yrt
17. Arginine Deiminase Pegylated
18. Pegargiminase [inn]
19. Pegargiminase [usan:inn]
20. Adi-peg 20
21. Adi-peg-20
22. Pegargiminase [usan]
23. Pegargiminase [who-dd]
24. Schembl4595689
25. Dtxsid301018299
26. Akos040741840
27. Bp-23437
28. Da-56666
29. Ms-31676
30. Sy272914
31. Hy-141236
32. Cs-0115035
33. Ns00076660
34. C70465
35. 1394129-74-8
36. Pentakis(n-(4-(.omega.-methoxypoly(oxyethylene))-4-oxobutanoyl))-(111-glutamic Acid,209-serine)arginine Deiminase (adi, Arginine Dihydrolase, Ad) From Mycoplasma Hominis
37. Pentakis(n-(4-(omega-methoxypoly(oxyethylene))-4-oxobutanoyl))-(111-glutamic Acid,209-serine)arginine Deiminase (adi, Arginine Dihydrolase, Ad) From Mycoplasma Hominis
Molecular Weight | 899.1 g/mol |
---|---|
Molecular Formula | C40H82O21 |
XLogP3 | -3.9 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 21 |
Rotatable Bond Count | 58 |
Exact Mass | Da |
Monoisotopic Mass | Da |
Topological Polar Surface Area | 216 |
Heavy Atom Count | 61 |
Formal Charge | 0 |
Complexity | 693 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in melanoma and hepatocellular carcinoma.
ABOUT THIS PAGE
51
PharmaCompass offers a list of Pegargiminase API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pegargiminase manufacturer or Pegargiminase supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pegargiminase manufacturer or Pegargiminase supplier.
PharmaCompass also assists you with knowing the Pegargiminase API Price utilized in the formulation of products. Pegargiminase API Price is not always fixed or binding as the Pegargiminase Price is obtained through a variety of data sources. The Pegargiminase Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pegargiminase manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pegargiminase, including repackagers and relabelers. The FDA regulates Pegargiminase manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pegargiminase API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pegargiminase supplier is an individual or a company that provides Pegargiminase active pharmaceutical ingredient (API) or Pegargiminase finished formulations upon request. The Pegargiminase suppliers may include Pegargiminase API manufacturers, exporters, distributors and traders.
Pegargiminase Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pegargiminase GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pegargiminase GMP manufacturer or Pegargiminase GMP API supplier for your needs.
A Pegargiminase CoA (Certificate of Analysis) is a formal document that attests to Pegargiminase's compliance with Pegargiminase specifications and serves as a tool for batch-level quality control.
Pegargiminase CoA mostly includes findings from lab analyses of a specific batch. For each Pegargiminase CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pegargiminase may be tested according to a variety of international standards, such as European Pharmacopoeia (Pegargiminase EP), Pegargiminase JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pegargiminase USP).